JP2019511221A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019511221A5 JP2019511221A5 JP2018547931A JP2018547931A JP2019511221A5 JP 2019511221 A5 JP2019511221 A5 JP 2019511221A5 JP 2018547931 A JP2018547931 A JP 2018547931A JP 2018547931 A JP2018547931 A JP 2018547931A JP 2019511221 A5 JP2019511221 A5 JP 2019511221A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleic acid
- virus
- dengue
- deletion
- serotype
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662307170P | 2016-03-11 | 2016-03-11 | |
| US62/307,170 | 2016-03-11 | ||
| PCT/US2017/021989 WO2017156511A1 (en) | 2016-03-11 | 2017-03-11 | Live attenuated zika virus vaccine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2019511221A JP2019511221A (ja) | 2019-04-25 |
| JP2019511221A5 true JP2019511221A5 (https=) | 2020-03-05 |
Family
ID=58428363
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018547931A Withdrawn JP2019511221A (ja) | 2016-03-11 | 2017-03-11 | 弱毒化された生ジカウイルスワクチン |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20190194260A1 (https=) |
| EP (1) | EP3426292A1 (https=) |
| JP (1) | JP2019511221A (https=) |
| KR (1) | KR20180127397A (https=) |
| CN (1) | CN109152828A (https=) |
| AU (1) | AU2017230112A1 (https=) |
| BR (1) | BR112018068342A2 (https=) |
| CA (1) | CA3016697A1 (https=) |
| CO (1) | CO2018010874A2 (https=) |
| MX (1) | MX2018010958A (https=) |
| WO (1) | WO2017156511A1 (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018010789A1 (en) | 2016-07-13 | 2018-01-18 | Humabs Biomed Sa | Novel antibodies specifically binding to zika virus epitopes and uses thereof |
| WO2018129160A1 (en) | 2017-01-06 | 2018-07-12 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Live attenuated flavivirus vaccines and methods of using and making same |
| WO2018152158A1 (en) * | 2017-02-14 | 2018-08-23 | Shi Pei Yong | Live attenuated zika virus with 3'utr deletion, vaccine containing and use thereof |
| WO2019042555A1 (en) | 2017-08-31 | 2019-03-07 | Humabs Biomed Sa | MULTISPECIFIC ANTIBODIES SPECIFICALLY BINDING TO ZIKA VIRUS EPITOPES AND USES THEREOF |
| GB201716307D0 (en) * | 2017-10-05 | 2017-11-22 | Univ Leuven Kath | Chimeric yellow fever zika virus strain |
| EP3710046A4 (en) * | 2017-11-10 | 2021-11-17 | The Research Institute at Nationwide Children's Hospital | RECOMBINANT VECTORS CODING FOR ZIKA VIRUS PROTEIN SUB-UNITS |
| EP3846848A4 (en) * | 2018-09-04 | 2022-07-06 | The Board of Regents of the University of Texas System | DNA PLASMID INITIATED LIVE VACCINES FOR PLUS-POLARITY SINGLE STRAND RNA VIRUS |
| CR20210677A (es) * | 2019-06-25 | 2022-04-26 | Codagenix Inc | Virus atenuados del dengue |
| EP4277641A4 (en) * | 2021-02-26 | 2025-03-19 | Duke University | Compositions for and methods of improving gene therapy |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU3815601A (en) | 2000-02-10 | 2001-08-20 | Us Health | Full-length infectious cDNA clones of tick borne flavivirus |
| DK2290109T3 (da) * | 2001-05-22 | 2014-11-10 | Us Gov Health & Human Serv | Udvikling af mutationer, der er anvendelige til svækkelse af dengue-vira samt kimære dengue-vira |
| JP4580650B2 (ja) | 2002-01-10 | 2010-11-17 | アメリカ合衆国 | 西ナイルウイルスにより引き起こされる疾患を予防するために生ウイルスワクチン中に用いるための西ナイルウイルスおよびデングウイルスキメラの構築 |
| ATE481982T1 (de) | 2002-05-03 | 2010-10-15 | Us Gov Health & Human Serv | Dengue-vakzine mit einer gemeinsamen 30 nukleotid-deletion im 3'-utr der dengue-typen 1 und 2. |
| CA2894300A1 (en) | 2003-12-08 | 2005-06-23 | The Government Of The United States Of America, As Represented By The Secreatary, Department Of Health And Human Services | Monoclonal antibodies that bind or neutralize dengue virus |
| US7851194B2 (en) | 2004-06-14 | 2010-12-14 | The United States Of America As Represented By The Department Of Health And Human Services | West Nile viruses with mutations in the 3′ terminal stem and loop secondary structure for use as live virus vaccines |
| DK2589602T3 (en) | 2006-08-15 | 2016-07-25 | The Government Of The U S A As Repr By The Secretary Dept Of Health & Human Services The Nat Inst Of | Development of dengue virus vaccine components |
| US20100316670A1 (en) | 2007-06-14 | 2010-12-16 | Blaney Joseph E | Chimeric sle/dengue type 4 antigenic viruses |
| US20120294889A1 (en) * | 2010-11-12 | 2012-11-22 | Paxvax, Inc. | Chimeric Flavivirus Vaccines |
-
2017
- 2017-03-11 AU AU2017230112A patent/AU2017230112A1/en not_active Abandoned
- 2017-03-11 KR KR1020187029244A patent/KR20180127397A/ko not_active Withdrawn
- 2017-03-11 JP JP2018547931A patent/JP2019511221A/ja not_active Withdrawn
- 2017-03-11 BR BR112018068342A patent/BR112018068342A2/pt not_active IP Right Cessation
- 2017-03-11 CA CA3016697A patent/CA3016697A1/en not_active Abandoned
- 2017-03-11 CN CN201780028836.4A patent/CN109152828A/zh active Pending
- 2017-03-11 US US16/083,652 patent/US20190194260A1/en not_active Abandoned
- 2017-03-11 WO PCT/US2017/021989 patent/WO2017156511A1/en not_active Ceased
- 2017-03-11 MX MX2018010958A patent/MX2018010958A/es unknown
- 2017-03-11 EP EP17714066.2A patent/EP3426292A1/en not_active Withdrawn
-
2018
- 2018-10-10 CO CONC2018/0010874A patent/CO2018010874A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019511221A5 (https=) | ||
| Hombach | Vaccines against dengue: a review of current candidate vaccines at advanced development stages | |
| Huang et al. | Dengue 2 PDK-53 virus as a chimeric carrier for tetravalent dengue vaccine development | |
| Beasley et al. | Envelope protein glycosylation status influences mouse neuroinvasion phenotype of genetic lineage 1 West Nile virus strains | |
| Guirakhoo et al. | Construction, safety, and immunogenicity in nonhuman primates of a chimeric yellow fever-dengue virus tetravalent vaccine | |
| Durbin et al. | Dengue vaccine candidates in development | |
| JP2019151636A5 (https=) | ||
| Chambers et al. | Yellow fever virus/dengue-2 virus and yellow fever virus/dengue-4 virus chimeras: biological characterization, immunogenicity, and protection against dengue encephalitis in the mouse model | |
| JP2015524421A5 (https=) | ||
| WO2017156511A8 (en) | Live attenuated zika virus vaccine | |
| WO2008022196A3 (en) | Development of dengue virus vaccine components | |
| Sun et al. | Basic amino acid substitution at residue 367 of the envelope protein of Tembusu virus plays a critical role in pathogenesis | |
| JP2017526689A5 (https=) | ||
| Lai et al. | Evaluation of molecular strategies to develop a live dengue vaccine | |
| RU2020132280A (ru) | Аттенуированные флавивирусы | |
| Abbo et al. | Comparative efficacy of Mayaro virus-like particle vaccines produced in insect or mammalian cells | |
| CO6541529A2 (es) | Método, plasmideo y composición para inducir una respuesta inmune contra virus de la dengue basado en vacunas de adn y virus quimericos | |
| Babaeimarzangou et al. | Vaccine development for zoonotic viral diseases caused by positive‑sense single‑stranded RNA viruses belonging to the Coronaviridae and Togaviridae families | |
| Kamath et al. | Dengue vaccines: Current status and future perspectives | |
| He et al. | Replication/assembly defective avian flavivirus with internal deletions in the capsid can be used as an approach for living attenuated vaccine | |
| Dias et al. | DENV-3 precursor membrane (prM) glycoprotein enhances E protein immunogenicity and confers protection against DENV-2 infections in a murine model | |
| Schepp-Berglind et al. | Complex adenovirus-mediated expression of West Nile virus C, PreM, E, and NS1 proteins induces both humoral and cellular immune responses | |
| EP2086526B1 (en) | Induction of an immune response against Dengue virus using prime-boost approach | |
| Baize et al. | Recent advances in vaccines against viral haemorrhagic fevers | |
| Chambers et al. | Chimeric Japanese encephalitis virus/dengue 2 virus infectious clone: biological properties, immunogenicity and protection against dengue encephalitis in mice |